BioSpace News Archive

CVS Health (NYSE: CVS) is recognizing its 30,000 pharmacists as part of American Pharmacists Month, an annual observation held in October.

The American Society for Radiation Oncology (ASTRO) announced today the 10 top-rated studies that will be highlighted in the press program for the 2018 ASTRO Annual Meeting.

CURE Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, is proud to announce that Chuck Pagano, Former NFL Coach, Motivational Speaker and Cancer Survivor, will be the guest speaker for the CURE® 2018 Chronic Lymphocytic Leukemia Heroes recognition ceremony.

Most people have never tasted a groundcherry; the small, sweet relative of the tomato that plant biologist Zachary Lippman describes as “tropically intoxicating.” That’s because the groundcherry plant, with its long, straggly branches and sporadically ripening fruit, is unsuitable for large-scale agriculture.

Agilent Technologies Inc. (NYSE: A) today introduced a new approach to chemical imaging that will bring greater clarity and unprecedented speed to pharmaceutical, biomedical, food, and materials science.

Survey results released today from the inaugural Clover Health Flu Shot Monitor reveal that only 63% of U.S. seniors age 60 and older plan to get a flu shot this season, prompting the Medicare Advantage insurer to implore all Americans to take the threat of the virus more seriously and get vaccinated before the end of October.

The SCOUT® Radar Breast Localization System was featured as the 2018 cutting edge technology for breast cancer patients as Good Morning America kicked off Breast Cancer Awareness Month. SCOUT, a non-radioactive, wire-free option for tumor and lymph node localization is available at over 350 hospitals across the United States and those numbers are growing.

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, congratulated Dr. James P. Allison, of the M.D. Anderson Cancer Center at the University of Texas, for his award as one of two recipients of the 2018 Nobel Prize in Medicine or Physiology for his pioneering work in immunotherapy that has transformed the way melanoma and many other cancers are now treated.

Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer’s disease (AD) and related neurodegenerative disorders, announced today the receipt of a Small Business Innovation Research (SBIR) Phase I/Phase II Fast-Track grant for $2.49 million from the National Institutes of Health (NIH), National Institute on Aging (NIA).

CrossFit, Inc. today announced that Wodapalooza, a global fitness festival and inclusive competition, is joining the roster as the 7th event to be sanctioned by CrossFit.